Top compounds associated with response to RP11-327P2.7


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.07
mRNA I-BET151 CTRPv2 pan-cancer AAC 0.055 0.07
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.07
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.08
mRNA RG-108 CTRPv2 pan-cancer AAC 0.065 0.08
mRNA BRD-K07442505 CTRPv2 pan-cancer AAC 0.066 0.08
mRNA paclitaxel CTRPv2 pan-cancer AAC -0.058 0.08
mRNA BRD-A71883111 CTRPv2 pan-cancer AAC 0.064 0.08
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.081 0.09
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.053 0.09
Download CSV